SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea flag South Korea · Delayed Price · Currency is KRW
102,600
+600 (0.59%)
At close: Jul 25, 2025, 3:30 PM KST

SK Biopharmaceuticals Market Cap

SK Biopharmaceuticals has a market cap or net worth of 7.99 trillion as of July 25, 2025. Its market cap has increased by 32.47% in one year.

Market Cap
7.99T
Enterprise Value
7.87T
Revenue
578.00B
Ranking
n/a
PE Ratio
31.80
Stock Price
102,600.00

Market Cap Chart

Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.99T, a decrease of -19.69%. That is a compound annual growth rate of -4.24%.

History

DateMarket Cap% Change
Jul 24, 20257,987.95B-8.19%
Dec 30, 20248,700.60B10.66%
Dec 28, 20237,862.65B39.25%
Dec 29, 20225,646.39B-25.82%
Dec 30, 20217,612.05B-42.49%
Dec 30, 202013.23T33.07%
Jul 2, 2020 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Samsung Biologics75.73T
Celltrion39.71T
ALTEOGEN25.60T
Yuhan9,359.37B
Peptron6,907.66B
HLB Co., Ltd.6,558.63B
PharmaResearch6,057.16B
LigaChem Biosciences5,227.55B
Market Cap Rankings